Related Experiment Video
Updated: Jan 28, 2026

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
People with chronic obstructive pulmonary disease exacerbations prefer early discharge, then treatment at home
Rob Cook1, Vaughan Thomas2, Rosie Martin3
1Bazian, Economist Intelligence Unit healthcare, London, UK rob.cook@bazian.com.
Insights
Home treatment for COPD exacerbations is as effective as hospital care for selected patients. This randomized trial supports hospital-at-home strategies for managing COPD flare-ups, improving patient outcomes.
Area of Science:
- Respiratory Medicine
- Health Services Research
- Clinical Trials
Background:
- COPD exacerbations frequently lead to hospital admissions.
- Identifying suitable patients for home treatment can optimize resource use and patient experience.
Purpose of the Study:
- To evaluate the non-inferiority of home treatment versus hospital care for COPD exacerbations.
- To conduct an economic evaluation of hospital-at-home treatment.
Main Methods:
- A non-inferiority, randomized controlled trial.
- Patients with COPD exacerbations were selected using the DECAF score.
- Comparison of outcomes and costs between home treatment and hospital care groups.
Main Results:
- Home treatment was found to be non-inferior to hospital care for selected COPD exacerbations.
- The study likely provides data on patient outcomes, safety, and cost-effectiveness.
Conclusions:
- Hospital-at-home treatment is a viable and effective alternative for managing selected COPD exacerbations.
- This approach may offer benefits in terms of patient preference and healthcare resource utilization.
Abstract:
The studyHome treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluationEchevarria C, Gray J, Hartley T, Miller J, Simpson AJ, Gibson GJ, Bourke SCPublished on 24 April 2018 Thorax 2018;73:713-22This project was funded by the National Institute for Health Research-Research for Patient Benefit Programme (project number PB-PG-0213-30105).To read the full NIHR Signal, go to: https://discover.dc.nihr.ac.uk/content/signal-000691/hospital-at-home-treatment-for-copd-flare-ups.
More Related Videos
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: